+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice

Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice

Hepatology 65(3): 836-852

Blocking hepatic very low-density lipoprotein secretion through genetic or pharmacologic inhibition of microsomal triglyceride transfer protein (Mttp) causes hepatic steatosis, yet the risks for developing hepatic fibrosis are poorly understood. We report that liver-specific Mttp knockout mice (Mttp-LKO) exhibit both steatosis and fibrosis, which is exacerbated by a high-transfat/fructose diet. When crossed into germline liver fatty acid (FA) binding protein null mice (Mttp-LKO, i.e., double knockout mice) hepatic steatosis was greatly diminished and fibrosis prevented, on both low-fat and high-fat diets. The mechanisms underlying protection include reduced long chain FA uptake, shifts in FA distribution (lipidomic profiling), and metabolic turnover, specifically decreased hepatic 18:2 FA and triglyceride species and a shift in 18:2 FA use for oxidation versus incorporation into newly synthesized triglyceride. Double knockout mice were protected against fasting-induced hepatic steatosis (a model of enhanced exogenous FA delivery) yet developed steatosis upon induction of hepatic de novo lipogenesis with fructose feeding. Mttp-LKO mice, on either the liver FA binding protein null or Apobec-1 null background (i.e., apolipoprotein B100 only) exhibited only subtle increases in endoplasmic reticulum stress, suggesting that an altered unfolded protein response is unlikely to account for the attenuated phenotype in double knockout mice. Acute, antisense-mediated liver FA binding protein knockdown in Mttp-LKO mice also reduced FA uptake, increased oxidation versus incorporation of 18:2 species with complete reversal of hepatic steatosis, increased hepatic injury, and worsened fibrosis. Perturbing exogenous hepatic FA use modulates both hepatic steatosis and fibrosis in the setting of hepatic Mttp deletion, adding new insight into the pathophysiological mechanisms and consequences of defective very low-density lipoprotein secretion. (Hepatology 2017;65:836-852).

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058621628

Download citation: RISBibTeXText

PMID: 27862118

DOI: 10.1002/hep.28941

Related references

Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. Journal of Biological Chemistry 281(44): 33066-33077, 2006

Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. Journal of Biological Chemistry 278(51): 51664-51672, 2003

Targeting L-Fabp attenuates Steatosis and Prevents Hepatic Fibrosis in Mice With Liver Specific Microsomal Triglyceride Transfer Protein Knockout (Mttp-Lko) By Changing Lipid Droplet Metabolism and Inducing Autophagy. Gastroenterology 150(4): S1025-S1026, 2016

Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein. Arteriosclerosis Thrombosis and Vascular Biology 32(7): 1624-1631, 2012

Etiology of fatty liver in dairy cattle: effects of nutritional and hormonal status on hepatic microsomal triglyceride transfer protein. Journal of Dairy Science 83(10): 2239-2251, 2000

Triglyceride and phospholipid binding to the bovine liver microsomal triglyceride transfer protein. FASEB Journal 7(7): A1268, 1993

Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth. Journal of Lipid Research 46(2): 320-327, 2005

Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. Expert Review of Gastroenterology and Hepatology 5(2): 245-251, 2011

Role of microsomal triglyceride transfer protein in induction of fatty liver in suncus. Hepatology Research 16(1): 19-25, 1999

Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein. British Journal of Nutrition 101(5): 680-687, 2009

Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biological Chemistry Hoppe-Seyler 370(3): 229-238, 1989

Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. Journal of Biological Chemistry 278(24): 21429-21438, 2003

Expression and methylation of microsomal triglyceride transfer protein and acetyl-CoA carboxylase are associated with fatty liver syndrome in chicken. Poultry Science 95(6): 1387-1395, 2016

Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells. Journal of Biological Chemistry 276(30): 28606-28612, 2001

Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. Journal of Clinical Investigation 103(9): 1287-1298, 1999